CAR-T therapies should be made by academic medical centers - STAT

CAR-T therapies should be made by academic medical centers - STAT

Letting academic medical centers make CAR-T drugs would save billions

By DAVID MITCHELL AND SAAD KENDERIAN AND S. VINCENT RAJKUMAR

GERARD JULIEN/AFP VIA GETTY IMAGES

CAR-T drugs for treating blood cancers could be made faster in academic medical centers, instead of by pharma companies, and save billions of dollars.

READ MORE